


The Fund aims to provide long-term capital growth.
| Name | % Net Assets |
|---|---|
| BP | 7.6% |
| Vodafone | 5.6% |
| GlaxoSmithKline | 4.9% |
| Royal Dutch Shell A | 4.8% |
| HSBC | 4.1% |
| Royal Dutch Shell B | 3.6% |
| FTSE 100 20/06/09 Future | 3.2% |
| AstraZeneca | 3.1% |
| BG Group | 3.1% |
| British American Tobacco | 2.8% |
| Key | % Net Assets |
|---|---|
| 7.6% | |
| 5.6% | |
| 4.9% | |
| 4.8% | |
| 77.1% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 1,043.00p |
| Currency | GBP |
| Change | 3.00p |
| % | 0.29% |
| YTD change | 130.10p |
| YTD % | 14.25% |
| Fund Inception | 15/09/1988 |
|---|---|
| Fund Manager | Terry Wood |
| TER | 0.38 (30-Apr-2011) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | £1,000 |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 0.30% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.09 |
You are here: research